# A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

> **NCT02991872** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 150 (actual)

## Conditions studied

- Virus Diseases

## Interventions

- **PROCEDURE:** Blood draw

## Key facts

- **NCT ID:** NCT02991872
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-16
- **Primary completion:** 2017-03-12
- **Final completion:** 2017-03-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02991872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02991872, "A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02991872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*